|
Volumn 28, Issue 1, 1997, Pages 48-53
|
Modified BFM protocol for childhood acute lymphoblastic leukemia: A retrospective analysis
a a a a |
Author keywords
BFM protocol; CNS involvement; disease free survival
|
Indexed keywords
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
TIOGUANINE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ARTICLE;
BLOOD TOXICITY;
CANCER SURVIVAL;
CHILD;
CLINICAL ARTICLE;
DOSE TIME EFFECT RELATION;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRATHECAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIFE TABLE;
MALE;
PRIORITY JOURNAL;
REMISSION;
SEPTICEMIA;
SURVIVAL TIME;
TREATMENT PLANNING;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
DAUNORUBICIN;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L2;
MALE;
PREDNISONE;
PROGNOSIS;
RECURRENCE;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
SURVIVAL;
VINCRISTINE;
|
EID: 0031021223
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-911X(199701)28:1<48::AID-MPO9>3.0.CO;2-T Document Type: Article |
Times cited : (9)
|
References (29)
|